{"name":"The Center for Rheumatic Disease, Allergy, & Immunology","slug":"the-center-for-rheumatic-disease-allergy-immunology","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"IV Gamunex 10%","genericName":"IV Gamunex 10%","slug":"iv-gamunex-10","indication":"Primary immunodeficiency","status":"phase_2"}]}],"pipeline":[{"name":"IV Gamunex 10%","genericName":"IV Gamunex 10%","slug":"iv-gamunex-10","phase":"phase_2","mechanism":"Immunomodulation through the administration of intravenous immunoglobulin","indications":["Primary immunodeficiency","Chronic inflammatory demyelinating polyneuropathy","Multifocal motor neuropathy"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOdUJJaGJCWVVlTWJnMU4wNnFZVjM3eGczZ3JrLVByV3hIY3FPeGVjTGpOQjJZWFBXRzhjYXNmYW05dWp1RF9Ta0EtYmdYeHlvM0hJcDgzaGlVZEVCMkdkWnh2aUFFQnJEOHFsOXFHSU5UX3o1UTdhdGZvckV2SEpELTVkaTNOQlRPTkJqTVlFWEgyZERnRHcxQmFocm81UzNENXI2b1R1UXVOLWR1Y1YxR193?oc=5","date":"2025-11-12","type":"pipeline","source":"BioSpace","summary":"Novartis, Vertex, More Optimizing Shots on Multiple Goals in Lucrative I&I Space - BioSpace","headline":"Novartis, Vertex, More Optimizing Shots on Multiple Goals in Lucrative I&I Space","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNTXFvbEhsTkFxY2pHV1ZfdXlWLWtXb2JWNVA2SV9TV1FkQzNreDlVS1lTRGhtRVNlYnh2VlhlUlNUNnMzaHIzVUxrVk5aRnJxSjAxd0hKd2JOSkdzc3pmZVVrOEFOM21NYWFzMU55SDdKRXRWdFhBLWw1UlBUVEFlZHBUaw?oc=5","date":"2025-09-16","type":"pipeline","source":"medicine.yale.edu","summary":"Fellow Focus in Four: Joshua Skydel, MD, Rheumatology, Allergy, and Immunology - medicine.yale.edu","headline":"Fellow Focus in Four: Joshua Skydel, MD, Rheumatology, Allergy, and Immunology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNM0RXcFNuN2s0XzdqbjI3VUFKajlmUTV2Vy10Ty1RbmhwYTZhYk9hdDFhV3ljYm5fTW1BR2RjeHRtYTRVTzdKbTNIeUZVZjUzZlBCTW92Zll0a1hkbEttRERtTjR6c3pzUDhLdWJvbEgyQlNSenQ3VHZ2Sm43ZFoyVDdvVExpUW4yUkt1ODd3UzVCU2xiM3lSRGg0SVBOMTRrSHJpNVdzaEJaSVhHS0JndDVPQ2JlQktxWVM1dU5R?oc=5","date":"2025-03-12","type":"patent","source":"Center for Biosimilars","summary":"Updates on the Use of Biosimilars for Pediatric Patients With Rheumatic Disease - Center for Biosimilars","headline":"Updates on the Use of Biosimilars for Pediatric Patients With Rheumatic Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPbE9UTUdWV01UaS1aLWJzUF9INVUzVERMcVJueV9GMWZnYkxTSmt1VHE4TU9sQ3JqVDdENlZMNElyWHpQcE5YOXBSMGpvYkZIRk5HNVVzSmh0dUNJX2FncVdpMUxUUmprdGZteU5Zek9pWFdvU09jYkpNY25ubDNMcnRGcTA2U0J3WHJabHRYcUs3Zw?oc=5","date":"2025-03-06","type":"pipeline","source":"Frontiers","summary":"Multidisciplinary approach to treating complex immune dysregulation disorders: an adaptive model for institutional implementation - Frontiers","headline":"Multidisciplinary approach to treating complex immune dysregulation disorders: an adaptive model for institutional imple","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxOUzZVOHdrcnRBcEFXWG4xcGUtTHdXZGlrSTRYSGhsTmtIWWRfTlNkUldEcThpQ0xxUENaeGx0d0cwSUlWVGhUWmEtV1JvV25lcWFWM3NYZnhPX2x1MWFObkFWY0NxUU0zMnlOTjRVbEpNOUh4bXVMWUplV1IweUJRa0NlWkNaVTZUR3ZGbDQzRmJnSUNlRlNkNVlsNU9mbGhJaVEwSVVaYkIzTmRNeHdDY2hZSFEzVVJwcXR3Tlh5VVpWeGtmM0VxM21SNjNJdw?oc=5","date":"2024-01-04","type":"pipeline","source":"European Medical Journal","summary":"Holistic Care of the Immunocompromised Rheumatologic Patient – Case Analysis - European Medical Journal","headline":"Holistic Care of the Immunocompromised Rheumatologic Patient – Case Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1TSkM3bWRNOXJBVjRQejJUeWZUY1NDWFRQeE5laUJXc25tNTloSTNWOWtOY0VZdmVmYzJzZ1FOa3ZXT3NkUW5WOU45WHBzZ0F1WHFxNHBCT0VqekRMYjhR?oc=5","date":"2023-11-08","type":"pipeline","source":"Nature","summary":"Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes - Nature","headline":"Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQaXN3ZGtZc1ZzdVF2YXZtcm5Ub2NlTXpweHllN0VTRGdHWG1XU3NZMXNUTDMzRXZlMV9tVExMVWo3aHBmZS1NSEptanlQc1N0dWNPV0hyS1N5MGNKSEFBUlpSdTk1WFBWbnk2bXVnU2JsaG8wZ3VUOU4yOEdjVy1UZ3VDcG9DUVpyZWw4ZkRPV3J6RVFSZFlTamJ5TQ?oc=5","date":"2023-07-11","type":"pipeline","source":"medicine.yale.edu","summary":"Rheumatology, Allergy and Immunology - medicine.yale.edu","headline":"Rheumatology, Allergy and Immunology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOd2dHaGkyNGtlc2pHeWw3ck9xdnhvUVBXWHFQWUczSWFsX3IzY0JxV1pIR2VwRU9iUlpKWHVYXzQ3aEhPbUxLVGs2ZkFEY3hwVEJXZkN4cUFWZ244QWczdnJNbHBGT2RINTloMWFsYzBPTlNuVWZXWVNySkZ2c0hPSUk4cTUzbGsyYUhLQ3pobVI2azl1VTVJdTJoRDV4U3VhNnc?oc=5","date":"2022-10-27","type":"pipeline","source":"medicine.yale.edu","summary":"Dr. Linda Bockenstedt and Dr. Richard Bucala Named ACR Masters - medicine.yale.edu","headline":"Dr. Linda Bockenstedt and Dr. Richard Bucala Named ACR Masters","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPZ19BUDJNUkFVejA4c2ZqLWRQck9Bb3lLVm80bUV1cHFEWWY2ajc2ZnhSR3RXampHU0dsU003X1dfbkpmMGU3TF96UHUtMHpmUWlpc016ZWQ1VmcwT1FsNTJFZTVHbHZMM2x0LTc3VjY3N0lTWXFwVE5GNGpTb1NXZExHNmQzckxEVGJiZFM2ckhHMEhnUVVhdW5R?oc=5","date":"2021-09-03","type":"pipeline","source":"Rheumatology Advisor","summary":"Managing Rheumatoid Arthritis in the COVID-19 Era - Rheumatology Advisor","headline":"Managing Rheumatoid Arthritis in the COVID-19 Era","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBMNUgzaFpsMk9HTG43RXdIazNlWTc2czFVQWN1X0pfOWhpWXJoRlIxTERZOFBMbGlFdENwYTBKRllzOWNrTmVQdlNpNzI2ZVFnQVA5azU1bm9UM2ZQWU84?oc=5","date":"2019-11-08","type":"regulatory","source":"Nature","summary":"Association of NCF1 polymorphism with systemic lupus erythematosus and systemic sclerosis but not with ANCA-associated vasculitis in a Japanese population - Nature","headline":"Association of NCF1 polymorphism with systemic lupus erythematosus and systemic sclerosis but not with ANCA-associated v","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQUVJZZ2VLb01VYzc4Q0pCdUlBaWZXWndlU0VyeFAwWmhxQnpkMFhqYXpoY2pSb1JKQzJkQndSTzVQWmt4dXZfbklSUWx2R193czVLeFhmWXpQMHVNaXd4MmQ4UXpjWGNGY0VTNlJDdjMtb1NWWHQydFNDcGJXY2wxZHY5Q1d6QQ?oc=5","date":"2018-08-09","type":"pipeline","source":"osaka-u.ac.jp","summary":"The Secret to the Strength of Immunology Research at Osaka University -- Over 100 Years of Tradition and Research - osaka-u.ac.jp","headline":"The Secret to the Strength of Immunology Research at Osaka University -- Over 100 Years of Tradition and Research - osak","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}